Compounds > methylprednisolone

methylprednisolone and zoledronic acid

methylprednisolone has been researched along with zoledronic acid in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's7 (53.85)24.3611
2020's4 (30.77)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bonfa, E; Caparbo, VF; Carvas, JS; Fuller, P; Lima, LA; Mello, SB; Pereira, RM; Silveira, CA1
Law, SK; Rahimy, E1
Finazzo, F; Manzoni, P; Militello, MA; Re, MP; Vitaliti, G; Vitaliti, SM1
Han, LS; Weatherhead, RG1
Aitken, D; Cai, G; Cicuttini, F; Hill, C; Jones, G; Laslett, LL; March, L; Martel-Pelletier, J; Pelletier, JP; Wluka, AE1
Bhansali, A; Das, L; Dutta, P; Jude, EB; Prakash, M; Rastogi, A1
Aitken, D; Bowes, MA; Cai, G; Cicuttini, F; Conaghan, PG; Hill, C; Jones, G; Laslett, LL; March, L; Winzenberg, T; Wluka, AE1

Reviews

1 review(s) available for methylprednisolone and zoledronic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for methylprednisolone and zoledronic acid

ArticleYear
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
    PloS one, 2021, Volume: 16, Issue:11

    Topics: Anti-Inflammatory Agents; Arthropathy, Neurogenic; Bone Density; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Neuropathies; Female; Humans; Inflammation; Male; Methylprednisolone; Middle Aged; Osteogenesis; Treatment Outcome; Zoledronic Acid

2021
Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial.
    Seminars in arthritis and rheumatism, 2022, Volume: 56

    Topics: Disease Progression; Female; Femur; Humans; Knee Joint; Male; Methylprednisolone; Osteoarthritis, Knee; Zoledronic Acid

2022

Other Studies

10 other study(ies) available for methylprednisolone and zoledronic acid

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:10

    Topics: Absorptiometry, Photon; Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Glucocorticoids; Imidazoles; Lumbar Vertebrae; Male; Methylprednisolone; Orthopedic Fixation Devices; Osseointegration; Osteoporosis; Prostheses and Implants; Rabbits; Tibia; Titanium; Zoledronic Acid

2010
Orbital inflammation after zoledronate infusion: an emerging complication.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2013, Volume: 48, Issue:1

    Topics: Aged; Blepharoptosis; Bone Density Conservation Agents; Diphosphonates; Edema; Exophthalmos; Eyelid Diseases; Glucocorticoids; Humans; Imidazoles; Infusions, Intravenous; Male; Methylprednisolone; Orbital Cellulitis; Osteoporosis; Tomography, X-Ray Computed; Zoledronic Acid

2013
Use of Zoledronic Acid in a Neonate with Subcutaneous Fat Necrosis Complicated with Severe, Refractory Hypercalcemia.
    American journal of perinatology, 2019, Volume: 36, Issue:S 02

    Topics: Bone Density Conservation Agents; Calcium; Drug Resistance; Fat Necrosis; Female; Furosemide; Glucocorticoids; Humans; Hypercalcemia; Infant, Newborn; Methylprednisolone; Sodium Potassium Chloride Symporter Inhibitors; Subcutaneous Fat; Term Birth; Zoledronic Acid

2019
Zoledronic acid associated orbital inflammation.
    Clinical & experimental ophthalmology, 2020, Volume: 48, Issue:2

    Topics: Bone Density Conservation Agents; Female; Glucocorticoids; Humans; Inflammation; Methylprednisolone; Middle Aged; Orbital Diseases; Osteoporosis, Postmenopausal; Tomography, X-Ray Computed; Zoledronic Acid

2020
The association between change in bone marrow lesion size and change in tibiofemoral cartilage volume and knee symptoms.
    Rheumatology (Oxford, England), 2021, 06-18, Volume: 60, Issue:6

    Topics: Arthralgia; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Diseases; Cartilage, Articular; Double-Blind Method; Female; Femur; Glucocorticoids; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multicenter Studies as Topic; Osteoarthritis, Knee; Randomized Controlled Trials as Topic; Tibia; Time Factors; Zoledronic Acid

2021